Entering text into the input field will update the search result below

Atossa Therapeutics issued patent covering breast cancer therapy endoxifen

Mar. 08, 2022 9:40 AM ETAtossa Therapeutics, Inc. (ATOS)By: Jonathan Block, SA News Editor

Patents files folder

oonal/iStock via Getty Images

  • The U.S. Patent and Trademark Office has granted Atossa Therapeutics (ATOS) a key patent covering its breast cancer therapy candidate endoxifen.
  • U.S. Patent No. 11,261,151 is titled “Methods for Making and Using Endoxifen.”
  • In September, Atossa (

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.